Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D S Compton"'
Publikováno v:
British journal of pharmacology. 134(2)
1. Ezetimibe potently inhibits the transport of cholesterol across the intestinal wall, thereby reducing plasma cholesterol in preclinical animal models of hypercholesterolemia. The effect of ezetimibe on known absorptive processes was determined in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8cc9de3f51ebdfaff7c0948dd1860956
https://pubmed.ncbi.nlm.nih.gov/11564660
https://pubmed.ncbi.nlm.nih.gov/11564660
Autor:
M, Van Heek, C F, France, D S, Compton, R L, McLeod, N P, Yumibe, K B, Alton, E J, Sybertz, H R, Davis
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 283(1)
SCH48461 is a selective and highly potent inhibitor of cholesterol absorption. In rats, SCH48461 is rapidly and completely metabolized in the first pass through the body. To compare the activity of the metabolites of SCH48461 with SCH48461 itself, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::982f096ca00a2bfd7e2077dddbe785fe
https://pubmed.ncbi.nlm.nih.gov/9336320
https://pubmed.ncbi.nlm.nih.gov/9336320
Autor:
M Van Heek, D S Compton, C F France, R P Tedesco, A B Fawzi, M P Graziano, E J Sybertz, C D Strader, H R Davis
Publikováno v:
The Journal of clinical investigation. 99(3)
Leptin administration reduces obesity in leptin-deficient ob/ob mice; its effects in obese humans, who have high circulating leptin levels, remain to be determined. This longitudinal study was designed to determine whether diet-induced obesity in mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35550cc929cc9d7f31a6a215c7b13694
https://pubmed.ncbi.nlm.nih.gov/9022070
https://pubmed.ncbi.nlm.nih.gov/9022070